Learning Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

  • INS 2026 Virtual Conference
    Contains 21 Product(s)

    The INS 2026 Virtual Conference is a great option for anyone who can’t join us in person. With 20 curated sessions available virtually and on-demand, CRNI®s can earn up to 40 recertification units (RUs) at their own pace. This year’s virtual lineup includes 3 specialty tracks—Vascular Access Devices, Alternative Care Settings, and Disease States—each designed to strengthen your infusion therapy practice from anywhere.

    The INS 2026 Virtual Conference is a great option for anyone who can’t join us in person. With 20 curated sessions available virtually and on-demand, CRNI®s can earn up to 40 recertification units (RUs) at their own pace. This year’s virtual lineup includes 3 specialty tracks—Vascular Access Devices, Alternative Care Settings, and Disease States—each designed to strengthen your infusion therapy practice from anywhere.

  • Targeting FcRn in generalized myasthenia gravis with rozanolixizumab-noli
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 02/18/2026 at 1:00 PM (EST)

    This session will cover rozanolixizumab-noli, a subcutaneous infusion that blocks neonatal Fc receptor (FcRn), in the management of anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive (Ab+) generalized myasthenia gravis (gMG) in adults. Within the evolving gMG treatment landscape, understanding its clinical application is key to supporting shared decision-making that aligns with patients’ unique needs and preferences. Learners will explore best practices for administration and review recent data from the Phase 3 MycarinG and extension studies. In this session, we will apply clinical insights to a patient case and explore practical strategies for incorporating rozanolixizumab-noli into treatment plans for adults with anti-AChR or anti-MuSK Ab+ gMG.

    image

    This session will cover rozanolixizumab-noli, a subcutaneous infusion that blocks neonatal Fc receptor (FcRn), in the management of anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive (Ab+) generalized myasthenia gravis (gMG) in adults. Within the evolving gMG treatment landscape, understanding its clinical application is key to supporting shared decision-making that aligns with patients’ unique needs and preferences. Learners will explore best practices for administration and review recent data from the Phase 3 MycarinG and extension studies. In this session, we will apply clinical insights to a patient case and explore practical strategies for incorporating rozanolixizumab-noli into treatment plans for adults with anti-AChR or anti-MuSK Ab+ gMG.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Apply best practices for the administration of rozanolixizumab-noli
    • Analyze and interpret recent clinical trial data for rozanolixizumab-noli in adults with anti-AChR or anti-MuSK Ab+ gMG
    • Personalize treatment strategies and goals using a patient case with gMG to foster critical thinking

    Deena Rodney, MSN, APRN, ATC, AQH

    Deena M. Rodney, MSN, APRN, ATC, AQH, started her nursing career as a bedside neurology and psychiatric nurse. Shortly into her career, she transitioned to a unit educator for the neuroscience department (neurology medicine, surgical, and intensive care unit [ICU]). She found her strength in educating and grew into an administrator position developing graduate nurse programs for specialty units and training preceptors. Ms Rodney also held her roots to neurology, and post-graduate, accepted her current position of 16 years as community neurology APRN, caring for general neurology patients and rounding at one of the largest hospitals in central Florida. As she honed her profession, she developed a strength in care for the neuromuscular patient. In her practice, Ms Rodney is able to manage all aspects of patient care, including involvement in research and monitoring patients in the infusion suite. She has a mutual passion to care for the whole person and to educate providers.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: February 18, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Advancing Infusion Safety Through Smart Pump EHR Interoperability
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 01/29/2026 at 1:00 PM (EST)

    This session examines how smart pump–electronic health record (EHR) interoperability improves infusion safety, accuracy, and workflow efficiency. Participants will explore how bidirectional data exchange between pumps and EHRs reduces manual programming errors and enhances clinical decision-making. The discussion will highlight key technical and clinical components that support safe, reliable integration, along with real-world outcomes demonstrating error reduction and workflow optimization. Common challenges, such as data mapping, validation, and user adoption will be addressed, with practical strategies for overcoming them. Attendees will also learn how to use interoperability data and continuous quality improvement (CQI) methods to monitor performance and drive ongoing safety improvements. By the end of the session, participants will gain a clear understanding of how to implement, sustain, and optimize interoperable infusion systems.

    image

    This session examines how smart pump–electronic health record (EHR) interoperability improves infusion safety, accuracy, and workflow efficiency. Participants will explore how bidirectional data exchange between pumps and EHRs reduces manual programming errors and enhances clinical decision-making. The discussion will highlight key technical and clinical components that support safe, reliable integration, along with real-world outcomes demonstrating error reduction and workflow optimization. Common challenges, such as data mapping, validation, and user adoption will be addressed, with practical strategies for overcoming them. Attendees will also learn how to use interoperability data and continuous quality improvement (CQI) methods to monitor performance and drive ongoing safety improvements. By the end of the session, participants will gain a clear understanding of how to implement, sustain, and optimize interoperable infusion systems.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Understand the role of smart pumps in enhancing infusion safety
    • Recognize the benefits and challenges of interoperability with clinical systems
    • Explain how smart pump EHR interoperability enhances infusion safety and workflow efficiency
    • Identify key technical and clinical components of interoperable infusion systems
    • Summarize current evidence and outcomes from interoperability implementations
    • Recognize common challenges and strategies for maintaining safe, reliable integration
    • Utilize data and CQI methods to monitor and improve interoperable infusion practices
    • Identify best practices for drug library programming and maintenance

    Sheryl Krause, PhD, RN, CEN, ACNS-BC

    Sheryl Krause, PhD, RN, CEN, ACNS-BC, worked as a bedside nurse in oncology, obstetrics, and the emergency department for 19 years before becoming a clinical nurse specialist (CNS) in the emergency department in 2005. As a CNS, Dr Krause is passionate about ensuring that nurses have access to technology that enhances patient safety without disrupting efficient and effective workflows. She completed her PhD in Nursing with a minor in Industrial and Systems Engineering in 2024. The study of human factors in health care informed her thinking about infusion therapy practices. While in the PhD program, she led a project to implement smart pump technology and interoperability. Dr Krause presented the related outcomes at the 2023 International Symposium on Human Factors and Ergonomics in Health Care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 29, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Optimizing Outcomes: Evidence-Based Approaches to Vascular Access Device Selection
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 01/28/2026 at 1:00 PM (EST)

    Selecting the appropriate vascular access device is critical when administering high-risk medications. Infusion nurses often face institutional barriers that prevent them from following evidence-based guidelines, leading to patient harm. This session provides an overview of the risks associated with incorrect device selection and introduces the INS 2024 Vesicant List as a tool for guiding safe infusion practices. Learners will explore how decision-making support tools can empower nurses to advocate for appropriate care. In this session, we will examine how clinical judgment, updated guidelines, and technology can work together to improve vascular access outcomes.

    image

    Selecting the appropriate vascular access device is critical when administering high-risk medications. Infusion nurses often face institutional barriers that prevent them from following evidence-based guidelines, leading to patient harm. This session provides an overview of the risks associated with incorrect device selection and introduces the INS 2024 Vesicant List as a tool for guiding safe infusion practices. Learners will explore how decision-making support tools can empower nurses to advocate for appropriate care. In this session, we will examine how clinical judgment, updated guidelines, and technology can work together to improve vascular access outcomes.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Review key factors that influence vascular access device (VAD) selection in clinical practice
    • Understand infusion-related considerations such as solution characteristics, administration methods, and therapy duration
    • Recognize patient and vessel-related risks associated with infusion therapy
    • Utilize educational resources to support informed, evidence-based decision-making for device selection

    Barb Nickel, APRN-CNS, CCRN, CRNI®

    Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist at a large health care system in the United States, responsible for staff development and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel has presented nationally and published in several peer-reviewed journals on infusion-related topics. She was the Chair of the 2024 INS Infusion Therapy Standards of Practice (SOP)Committee, and is now Chair of the 2027 INS SOP Committee. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 28, 2029

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Season 2 Episode 3: January 30, 2026 | Expanding Protection Against CABSI and CLABSI
    Contains 0 Component(s)

    Sponsored by: Solventum. In this episode, DJ Shannon, an infection preventionist, discusses the challenges and advancements in preventing central line-associated bloodstream infections (CLABSIs) and catheter-associated bloodstream infections (CABSI). The conversation covers persistent challenges faced by clinicians, the impact of bloodstream infections on health care systems, evolving standards in infection prevention, and the importance of collaboration among health care professionals. Mr Shannon also highlights innovations in vascular access protection and the significance of clinician confidence in adopting new practices.

    image

    In this episode, DJ Shannon, an infection preventionist, discusses the challenges and advancements in preventing catheter-associated bloodstream infections (CLABSIs) and catheter-associated bloodstream infections (CABSI). The conversation covers persistent challenges faced by clinicians, the impact of bloodstream infections on health care systems, evolving standards in infection prevention, and the importance of collaboration among health care professionals. Mr Shannon also highlights innovations in vascular access protection and the significance of clinician confidence in adopting new practices.

    Host: Derek Fox, MSN, RN, VA-BC, CRNI®, NEA-BC

    Guest: DJ Shannon, MPH, CIC, VA-BC, FAPIC

    In this episode, DJ Shannon, an infection preventionist, discusses the challenges and advancements in preventing central line-associated bloodstream infections (CLABSIs) and catheter-associated bloodstream infections (CABSI). The conversation covers persistent challenges faced by clinicians, the impact of bloodstream infections on health care systems, evolving standards in infection prevention, and the importance of collaboration among health care professionals. Mr Shannon also highlights innovations in vascular access protection and the significance of clinician confidence in adopting new practices.

    image

    image

  • Season 2 Episode 2: January 28, 2026 | The Hidden Burden: Tackling CLABSI and CRBSI to Elevate Patient Safety
    Contains 0 Component(s)

    Sponsored by: BD. In this episode of the INS Infusion Room, Dr Nathan Gilmore discusses the burden of central line-associated bloodstream infections (CLABSIs) and catheter-related bloodstream infections (CRBSIs), emphasizing the importance of sterile procedures and teamwork in preventing these infections. He shares insights on the impact of these infections on health care costs, patient outcomes, and the role of technology and education in reducing infection rates. Dr Gilmore also highlights the significance of maintaining a culture of zero CLABSIs and the collaborative efforts needed to achieve this goal.

    image

    In this episode of the INS Infusion Room, Dr Nathan Gilmore discusses the burden of central line-associated bloodstream infections (CLABSIs) and catheter-related bloodstream infections (CRBSIs), emphasizing the importance of sterile procedures and teamwork in preventing these infections. He shares insights on the impact of these infections on health care costs, patient outcomes, and the role of technology and education in reducing infection rates. Dr Gilmore also highlights the significance of maintaining a culture of zero CLABSIs and the collaborative efforts needed to achieve this goal.

    Host: Derek Fox, MSN, RN, VA-BC, CRNI®, NEA-BC

    Guest: Dr Nathan Gilmore, MD, MBA

    In this episode of the INS Infusion Room, Dr Nathan Gilmore discusses the burden of central line-associated bloodstream infections (CLABSIs) and catheter-related bloodstream infections (CRBSIs), emphasizing the importance of sterile procedures and teamwork in preventing these infections. He shares insights on the impact of these infections on health care costs, patient outcomes, and the role of technology and education in reducing infection rates. Dr Gilmore also highlights the significance of maintaining a culture of zero CLABSIs and the collaborative efforts needed to achieve this goal.

    image

    image

  • Season 2 Episode 1: January 26, 2026 | From Standards to Practice: Managing Shared Volume and Concurrent Infusions
    Contains 2 Component(s)

    Sponsored by: Fresenius Kabi. In this episode of the INS Infusion Room, Barb Nickel discusses the critical topics of concurrent flow and shared volume in infusion therapy. She emphasizes the importance of understanding these concepts for patient safety, particularly in critical care settings. The conversation covers the risks associated with concurrent flow, the standards and best practices in infusion therapy, and the significance of pump function and medication delivery. Ms Nickel also highlights the need for better education among nurses regarding tubing characteristics and the management of peripheral IVs. The episode concludes with a call to action for clinicians to advocate for optimal patient care and to implement best practices in their daily routines.

    image

    In this episode of the INS Infusion Room, Barb Nickel discusses the critical topics of concurrent flow and shared volume in infusion therapy. She emphasizes the importance of understanding these concepts for patient safety, particularly in critical care settings. The conversation covers the risks associated with concurrent flow, the standards and best practices in infusion therapy, and the significance of pump function and medication delivery. Ms Nickel also highlights the need for better education among nurses regarding tubing characteristics and the management of peripheral IVs. The episode concludes with a call to action for clinicians to advocate for optimal patient care and to implement best practices in their daily routines.

    Host: Derek Fox, MSN, RN, VA-BC, CRNI®, NEA-BC

    Guest: Barb Nickel, MSN, APRN-CNS, CRNI®, CCRN

    In this episode of the INS Infusion Room, Barb Nickel discusses the critical topics of concurrent flow and shared volume in infusion therapy. She emphasizes the importance of understanding these concepts for patient safety, particularly in critical care settings. The conversation covers the risks associated with concurrent flow, the standards and best practices in infusion therapy, and the significance of pump function and medication delivery. Ms Nickel also highlights the need for better education among nurses regarding tubing characteristics and the management of peripheral IVs. The episode concludes with a call to action for clinicians to advocate for optimal patient care and to implement best practices in their daily routines.

    image

    Sponsored by:

    image

  • Season 1 Episode 23: December 30, 2025 - INS Infusion Room: A Year in Review with Dr Marlene Steinheiser
    Contains 2 Component(s)

    In this episode of the INS Infusion Room, Dr Marlene Steinheiser, Chief Clinical Officer at INS, joins the host to discuss the achievements and initiatives of the past year, as well as future plans for the organization. The conversation covers collaborations with various associations, the importance of vascular access, and the impact of educational programs. Enjoy the recap of the best moments of Season 1 as Dr Steinheiser and Derek prepare for the start of Season 2.

    In this episode of the INS Infusion Room, Dr Marlene Steinheiser, Chief Clinical Officer at INS, joins the host to discuss the achievements and initiatives of the past year, as well as future plans for the organization. The conversation covers collaborations with various associations, the importance of vascular access, and the impact of educational programs. Enjoy the recap of the best moments of Season 1 as Dr Steinheiser and Derek prepare for the start of Season 2. 

    Marlene Steinheiser, PhD, RN, CRNI®

    Dr Marlene Steinheiser, Chief Clinical Officer at INS, is responsible for supporting the vision and mission of the organization nationally and globally, which includes strategic planning and development of new programs, research, and education. Additionally, she provides leadership and oversight for the Editor-in-Chief of the Journal of Infusion Nursing and the Editor in Chief of the Infusion Therapy Standards of Practice, ensuring alignment with the organization’s strategic vision and publication standards.

    Dr Steinheiser has been a CRNI® since 1991 and has 39 years of nursing experience. Her background includes work in diverse clinical settings, faculty roles in both pre-licensure and post-licensure nursing education, and service as a nurse practice consultant for a state nursing regulatory board. Her passion for infusion therapy and vascular access has been integrated into each of her varied career roles.

    Dr Steinheiser holds a PhD from the University of Arizona, a master’s degree and a Bachelor of Science in nursing from the University of Akron, and a nursing diploma from Cleveland Metropolitan General Hospital School of Nursing. She conducts research on infusion therapy and vascular access topics, with a particular interest in mixed methods research and qualitative data analysis. She also presents nationally and internationally on infusion therapy and vascular access topics.

    Host: Derek Fox, MSN, RN, VA-BC, CRNI®, NEA-BC

    Guest: Marlene Steinheiser, PhD, RN, CRNI® 

    In this episode of the INS Infusion Room, Dr Marlene Steinheiser, Chief Clinical Officer at INS, joins the host to discuss the achievements and initiatives of the past year, as well as future plans for the organization. The conversation covers collaborations with various associations, the importance of vascular access, and the impact of educational programs. Enjoy the recap of the best moments of Season 1 as Dr Steinheiser and Derek prepare for the  start of Season 2. 

  • Season 1 Episode 22: December 16, 2025 - ECG for PICC Tip Confirmation: Louisiana’s Practice Shift You Need to Hear About
    Contains 2 Component(s)

    In this episode of the INS Infusion Room, host Derek speaks with Carla Dillard about her extensive experience in nursing and the recent changes in the scope of practice for nurses in Louisiana. They discuss the introduction of electrocardiogram (ECG) technology for confirming catheter placements, the challenges faced in advocating for this change, and the successful presentation to the Louisiana Board of Nursing. Ms Dillard emphasizes the importance of data-driven advocacy and collaboration among nurses to improve patient care and outcomes.

    In this episode of the INS Infusion Room, host Derek speaks with Carla Dillard about her extensive experience in nursing and the recent changes in the scope of practice for nurses in Louisiana. They discuss the introduction of electrocardiogram (ECG) technology for confirming catheter placements, the challenges faced in advocating for this change, and the successful presentation to the Louisiana Board of Nursing. Ms Dillard emphasizes the importance of data-driven advocacy and collaboration among nurses to improve patient care and outcomes.

    Carla Dillard, MSN, RN, VA-BC

    Carla Dillard, MSN, RN, VA-BC, serves as the Senior Clinical Advisor at Dynamic Access, a specialty she has embraced since 2005. Dynamic Access is committed to providing essential vascular access services across diverse settings, including acute care facilities, long-term care centers, nursing homes, and various organizations in 25 states across the United States. Throughout her journey, Carla has had the privilege of taking on various leadership roles, empowering her to make meaningful contributions to her organization’s clinical, operational, and educational initiatives.

    Host: Derek Fox, MSN, RN, VA-BC, CRNI®, NEA-BC

    Guest: Carla Dillard, MSN, RN, VA-BC

    In this episode of the INS Infusion Room, host Derek speaks with Carla Dillard about her extensive experience in nursing and the recent changes in the scope of practice for nurses in Louisiana. They discuss the introduction of electrocardiogram (ECG) technology for confirming catheter placements, the challenges faced in advocating for this change, and the successful presentation to the Louisiana Board of Nursing. Ms Dillard emphasizes the importance of data-driven advocacy and collaboration among nurses to improve patient care and outcomes.

  • Immediate-Use Compounding
    Contains 3 Component(s), Includes Credits Recorded On: 12/10/2025

    As health-care professionals, we are entrusted with making sure that every compounded sterile preparation (CSP) is accurate and carries the lowest possible risk of contamination. It is preferred that CSPs are prepared in a pharmacy’s ISO-5 compounding suite. However, there are occasions when patient needs require us to prepare medications outside of those controlled settings. This course will take an in-depth look at the minimum requirements as well as the best practices for maintaining patient safety when sterile drugs are mixed in environments outside of a cleanroom.

    image

    As health-care professionals, we are entrusted with making sure that every compounded sterile preparation (CSP) is accurate and carries the lowest possible risk of contamination. It is preferred that CSPs are prepared in a pharmacy’s ISO-5 compounding suite. However, there are occasions when patient needs require us to prepare medications outside of those controlled settings. This course will take an in-depth look at the minimum requirements as well as the best practices for maintaining patient safety when sterile drugs are mixed in environments outside of a cleanroom. 

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Define immediate-use compounding under USP <797> (2023)
    • Identify and understand the seven criteria that qualify preparation as an immediate-use CSP, exempting it from full USP <797> requirements
    • Describe best practices for reducing the risk of contamination when compounding for immediate use outside of ISO-5 conditions
    • Explain the distinction between compounding and preparation by approved labeling

    Maegan Brehm, PharmD

    Maegan Brehm, PharmD, is a Clinical Operations Pharmacist with WeInfuse and RxToolKit, where she promotes clinical safety initiatives. Dr Brehm graduated from the University of Nebraska Medical Center and began her career managing a high-volume retail pharmacy. She then transitioned to sterile compounding and home infusion care at Option Care Health and later to a critical access hospital in Nebraska. Her current work includes developing clinical competencies and RxWorkflow tools through RxToolKit and providing expert advice and real-world insight to the WeInfuse software engineering team. Dr Brehm brings over 12 years of experience in infusion therapy, sterile compounding, and staff education. She has a passion for improving patient safety, mentoring learners, and translating complex standards into practical solutions.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: December 10, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.